Ferring International Center

Ferring Pharmaceuticals is a research-driven, specialty biopharmaceutical group headquartered in Saint-Prex, Switzerland, with its primary corporate hub at the Ferring International Center. The company is a global leader in reproductive medicine and maternal health, while maintaining a significant presence in gastroenterology, urology, and endocrinology. Ferring is recognized for its expertise in peptide-based therapeutics and has recently expanded into cutting-edge fields including microbiome-based therapies and gene therapy. Its commercial portfolio features high-impact products such as Menopur for infertility, Rebyota for recurrent C. difficile infection, and Adstiladrin for bladder cancer. Operating in over 50 countries and distributing products to more than 100, with a workforce of approximately 7,000 employees, Ferring remains a privately held entity focused on long-term innovation in specialized care.